Decoding Death and Dying in people with Dementia by Digital thanotyping

ERC (European Research Council)HORIZON-ERCID: 101088414
EC Contribution
€20,000
Consortium Size
1 orgs
Start Year
2024
Summary

How can we recognize that a person with dementia is at the end of life? When we are dying, our physical, mental, and social abilities are gradually declining. No reliable method of predicting perceived dying currently exists although the technology is available (sensors, algorithms). The aim of Decoding Death and Dying in Dementia by Digital thanotyping (5-D) is to provide methods and tools to diagnose and describe dying to an unprecedented level of accuracy and robustness, within a timespan larger than is possible now, focusing on the case of dying people with dementia as one of the most vulnerable and difficult to study groups. 5-D combines clinical assessment tools with wearable sensing technology to monitor a) pain and distressing symptoms, b) behavioral and psychological symptoms in dementia (BPSD), c) oral changes, and to decode “the point of no return” as the beginning of perceived dying. To obtain this outcome in nursing home patients with dementia, I will test the main hypothesis: from monitoring the evolution of thanotype components over time and their interdependencies, the prediction of the “point of no return” is possible. The objectives of 5-D are:O1. Collect data using sensors and validated assessment scales. O2. Develop estimation methods for BPSD from sensor measurements. O3. Develop digital tools to capture the expression of pain.O4. Determine the relationship between breathing and oral symptoms. O5. Develop models for symptom interdependencies at the end of life and the “point of no return”. O6. Perform human-in-the-loop validation of developed tools, models, and algorithms.The ground-breaking interdisciplinary novelty of 5-D endeavors to enhance our understanding of end-of-life underlying pain and symptoms in people with dementia. Advancing our theoretical knowledge to uncover how, when, and why perceived dying can be identified opens the doors for transferable research across several scientific fields.

Consortium (1)

Project Results (14)

Source: CORDIS, the EU research results database.

Publications (13)
Activity and Behavioral Recognition Using Sensing Technology in Persons with Parkinson’s Disease or Dementia: An Umbrella Review of the Literature
Sensors· 2025DOI
Lydia D. Boyle, Lionel Giriteka, Brice Marty, Lucas Sandgathe, Kristoffer Haugarvoll, Ole Martin Steihaug, Bettina S. Husebo, Monica Patrascu
BMC Medicine
BMC Medicine· 2025DOI
Monica Patrascu; Line I. Berge; Ipsit V. Vahia; Brice Marty; Wilco P. Achterberg; Heather Allore; Richard R. Fletcher; Bettina S. Husebo
Cross-evaluation of wearable data for use in Parkinson’s disease research: a free-living observational study on Empatica E4, Fitbit Sense, and Oura
BioMedical Engineering OnLine· 2025DOI
Haakon Reithe, Brice Marty, Juan C. Torrado, Elise Førsund, Bettina S. Husebo, Ane Erdal, Simon U. Kverneng, Erika Sheard, Charalampos Tzoulis, Monica Patrascu
Digital phenotyping from heart rate dynamics: Identification of zero-poles models with data-driven evolutionary learning
Computers in Biology and Medicine· 2025DOI
Adrian Patrascu, Andreea Ion, Maarja Vislapuu, Bettina S. Husebo, Irina Andra Tache, Haakon Reithe, Monica Patrascu
Early childhood caries risk prediction using machine learning approaches in Bangladesh
BMC Oral Health· 2025DOI
Fardous Hasan, Maha El Tantawi, Farzana Haque, Moréniké Oluwátóyìn Foláyan, Jorma I. Virtanen
Growth Hormone Alters Remapping in the Hippocampal Area CA1 in a Novel Environment
eneuro· 2025DOI
Kamilla G. Haugland, Sondre Valentin Jordbræk, Erik Knutsen, Kirsten B. Kjelstrup, Vegard H. Brun
Selecting a smartwatch for trials involving older adults with neurodegenerative diseases: A researcher’s framework to avoid hidden pitfalls
Journal of Biomedical Informatics· 2025DOI
Lydia D. Boyle, Brice Marty, Kristoffer Haugarvoll, Ole Martin Steihaug, Monica Patrascu, Bettina S. Husebo
Feedback System Analysis of a Multicomponent Intervention on Dyads of Home-Dwelling Persons With Dementia and Their Caregivers: Results From the LIVE@Home.Path Trial
Innovation in Aging· 2024DOI
Maarja Vislapuu, Monica Patrascu, Heather Allore, Bettina S Husebo, Egil Kjerstad, Marie H Gedde, Line I Berge
Impact of Pain and Neuropsychiatric Symptoms on Activities in Nursing Home Residents (COSMOS Trial)
Journal of the American Medical Directors Association· 2024DOI
Sifra H. van de Beek, Ane Erdal, Bettina S. Husebø, Maarja Vislapuu, Wilco P. Achterberg, Monique A.A. Caljouw
Impact of Pain and Neuropsychiatric Symptoms on Activities in Nursing Home Residents (COSMOS Trial)
Journal of the American Medical Directors Association· 2024DOI
Sifra H. van de Beek, Ane Erdal, Bettina S. Husebø, Maarja Vislapuu, Wilco P. Achterberg, Monique A.A. Caljouw
Oral symptoms in dying nursing home patients. Results from the prospective REDIC study
BMC Oral Health· 2024DOI
Reidun K. N.M. Sandvik, Bettina S. Husebo, Geir Selbaek, Gunhild Strand, Monica Patrascu, Manal Mustafa, Sverre Bergh
The Difficulties of Managing Pain in People Living with Frailty: The Potential for Digital Phenotyping
Drugs & Aging· 2024DOI
Jemima T. Collins, David A. Walsh, John R. F. Gladman, Monica Patrascu, Bettina S. Husebo, Esmee Adam, Alison Cowley, Adam L Gordon, Giulia Ogliari, Hanneke Smaling, Wilco Achterberg
The effect of paracetamol on care dependency and daily functioning in persons with advanced dementia living in long-term care facilities
BMC Geriatrics· 2024DOI
Paulien H van Dam, Wilco P Achterberg, Bettina S Husebo, Monique AA Caljouw
Deliverables (1)
Data Management Plan